Biopharmaceutical News and Research

RSS

Fluence Analytics announces distribution agreement with Nihon Rufuto in Japan

Fluence Analytics, a manufacturer of industrial and laboratory analytics products, today announced it has signed a distribution agreement with Nihon Rufuto, a Japanese company specializing in the import and domestic sales of scientific instruments.

From Yokogawa Fluence Analytics 7 Jun 2018

Hamilton Robotics and Waters Corporation Collaborate Introduce STARWorks

Hamilton Robotics and Waters Corporation further extend their collaborative goal of streamlining biopharmaceutical sample preparation workflows with the launch of STARWorks for Waters.

4 Jun 2018

Opdivo plus low-dose Yervoy shows promising results in treating renal cell carcinoma patients

Bristol-Myers Squibb Company today announced patient-reported outcomes data from the Phase 3 CheckMate -214 trial in intermediate- and poor-risk patients with advanced renal cell carcinoma treated with the Immuno-Oncology combination Opdivo plus low-dose Yervoy versus sunitinib over a two-year follow-up period.

1 Jun 2018

Celgene to share new and updated data around novel hematological therapies

Celgene Corporation today announced that data from a broad range of early and late stage studies evaluating Celgene investigational agents and investigational uses of marketed products will be presented at the 23rd European Hematology Association annual meeting in Stockholm, Sweden, from June 14-17, 2018.

22 May 2018

PanOptica doses first patient in Phase 1/2 dose-ranging clinical trial of PAN-90806

PanOptica, Inc., a private biopharmaceutical company focused on developing innovative ophthalmology therapies, today announced that the Company has dosed the first patient in a Phase 1/2 dose-ranging clinical trial of PAN-90806, a once-daily topical eye drop formulation of a small-molecule anti-vascular endothelial growth factor (anti-VEGF) for the treatment of neovascular eye diseases.

22 May 2018

Investigational drug offers hope of relief for celiac disease patients exposed to gluten

An investigational new drug offers hope of relief for celiac disease patients who are inadvertently exposed to gluten while on a gluten-free diet.

22 May 2018

Pfizer starts Phase 1/2 study of RSV vaccine candidate in healthy adult volunteers

Pfizer Inc. today announced that it has started a Phase 1/2 trial of its respiratory syncytial virus (RSV) vaccine candidate in healthy adult volunteers. RSV is a common respiratory virus that affects the lungs and airways, with significant impact on young children and older adults.

22 May 2018

Pfizer announces Phase 3 study results of LYRICA Oral Solution CV for pediatric epilepsy patients

Pfizer Inc. announced today positive top-line results of a Phase 3 study examining the use of LYRICA® Oral Solution CV as adjunctive therapy for partial onset seizures in pediatric epilepsy patients one month to less than four years of age.

17 May 2018

Senior diabetic patients can save significant cost if negotiated rebates are shared at pharmacy counter

Sharing a portion of negotiated rebates at the pharmacy counter could save seniors in Medicare with diabetes more than $350 annually, according to a new analysis from IHS Markit.

17 May 2018

FutureNeuro and GreenLight Medicines team up to develop cannabis-based treatments for epilepsies

A new partnership between FutureNeuro, the SFI Research Centre for Chronic and Rare Neurological diseases based at RCSI and GreenLight Medicines, an indigenous Irish biopharmaceutical company has been formed to develop new cannabis-based treatments for drug-resistant epilepsies, and in particular, childhood epilepsies.

17 May 2018

Scientists find fast way to manipulate cell's cilia

Scientists at Johns Hopkins Medicine and the National Tsing Hua University in Taiwan say they have found a fast way to manipulate a cell's cilia, the tiny, fingerlike protrusions that "feel" and sense their microscopic environment.

16 May 2018

Aravive Biologics demonstrates proof-of-mechanism for AVB-S6-500 in ongoing phase 1 study

Aravive Biologics, Inc. announced today that the company has demonstrated clinical proof-of-mechanism for AVB-S6-500 in neutralizing GAS6, based on analysis of the single ascending dose portion of the ongoing Phase 1 study.

10 May 2018

Accelerator Life Science Partners launches new company to develop novel therapy for seizure disorders

Accelerator Life Science Partners (Accelerator), a leading life science investment and management firm, today announced that it has launched Proniras Corporation, a company developing tezampanel for the treatment of a variety of seizure disorders.

27 Apr 2018

PAREXEL appoints Peyton Howell as chief commercial and strategy officer

PAREXEL International Corporation, the world’s leading innovator of biopharmaceutical services, today announced the appointment of Peyton Howell as Chief Commercial and Strategy Officer, effective May 7, 2018. Ms. Howell most recently served as Executive Vice President at AmerisourceBergen and will be responsible for leading PAREXEL’s commercial strategy, including global sales, customer service and sales operations.

From Parexel 27 Apr 2018

Sartorius Stedim Biotech launches mini bioreactor vessel for ambr 250 high throughput system

Sartorius Stedim Biotech, a leading international supplier for the biopharmaceutical industry today announced the launch of a new mini bioreactor vessel for its ambr 250 high throughput system.

From Sartorius 23 Apr 2018

Sartorius and Penn State partner to advance teaching and research in biotechnology

Sartorius Stedim Biotech and Penn State University have entered into a collaborative partnership to advance multidisciplinary teaching and research in biotechnology. This long-term relationship will support the education and preparation of the next generation of biotechnology leaders.

From Sartorius 17 Apr 2018

Sartorius Stedim Biotech selected by ABL Europe to supply single-use process technologies

Sartorius Stedim Biotech S.A., a leading international technology partner of the biopharmaceutical industry, has been selected by ABL Europe as its primary supplier of single-use systems.

From Sartorius 21 Mar 2018

Sartorius Stedim Biotech unveils new ambr 250ht perfusion system for cell culture process development

Sartorius Stedim Biotech, a leading international supplier for the biopharmaceutical industry today announced the launch of the ambr 250 high throughput (ht) perfusion, a new automated parallel bioreactor system.

From Sartorius 15 Mar 2018

PAREXEL and CHA collaborate to improve early phase clinical development in Korea

PAREXEL International Corporation, the world’s leading innovator of biopharmaceutical services, today announced an alliance with CHA Medical Group to enhance early phase clinical development in Korea.

From Parexel 14 Mar 2018

Sartorius Stedim Biotech introduces new versions of data analytics software solutions

Sartorius Stedim Biotech, a leading international supplier for the biopharmaceutical industry, has introduced a new version of its SIMCA and SIMCA-online data analytical solutions, which are offered by its subsidiary Sartorius Stedim Data Analytics, formerly known as Umetrics.

From Sartorius 13 Mar 2018

Biopharmaceutical News and Research

Fluence Analytics announces distribution agreement with Nihon Rufuto in Japan

Hamilton Robotics and Waters Corporation Collaborate Introduce STARWorks

Opdivo plus low-dose Yervoy shows promising results in treating renal cell carcinoma patients

Celgene to share new and updated data around novel hematological therapies

PanOptica doses first patient in Phase 1/2 dose-ranging clinical trial of PAN-90806

Investigational drug offers hope of relief for celiac disease patients exposed to gluten

Pfizer starts Phase 1/2 study of RSV vaccine candidate in healthy adult volunteers

Pfizer announces Phase 3 study results of LYRICA Oral Solution CV for pediatric epilepsy patients

Senior diabetic patients can save significant cost if negotiated rebates are shared at pharmacy counter

FutureNeuro and GreenLight Medicines team up to develop cannabis-based treatments for epilepsies

Scientists find fast way to manipulate cell's cilia

Aravive Biologics demonstrates proof-of-mechanism for AVB-S6-500 in ongoing phase 1 study

Accelerator Life Science Partners launches new company to develop novel therapy for seizure disorders

PAREXEL appoints Peyton Howell as chief commercial and strategy officer

Sartorius Stedim Biotech launches mini bioreactor vessel for ambr 250 high throughput system

Sartorius and Penn State partner to advance teaching and research in biotechnology

Sartorius Stedim Biotech selected by ABL Europe to supply single-use process technologies

Sartorius Stedim Biotech unveils new ambr 250ht perfusion system for cell culture process development

PAREXEL and CHA collaborate to improve early phase clinical development in Korea

Sartorius Stedim Biotech introduces new versions of data analytics software solutions

Event guide: 3rd EHS for Biopharma Summit eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News